靶向K47型肺炎克雷伯菌抗菌蛋白的鉴定及其特异性分子基础研究
批准号:
82102446
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
刘艳楠
依托单位:
学科分类:
病原生物与感染研究新技术与新方法
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
刘艳楠
中文摘要
肺炎克雷伯菌(简称“肺克”)是引起院内外感染的重要致病菌之一,其耐药性逐年增强,给临床治疗带来巨大挑战。噬菌体及其来源抗菌蛋白能够有效杀灭细菌,有望作为抗生素替代或补充的有效手段。然而,噬菌体及其抗菌蛋白的宿主特异性较强,且其特异性分子基础尚不清楚。此前,申请人从一株肺克噬菌体中鉴定出两种解聚酶类抗菌蛋白,具有较好的抗菌效果。进一步研究发现,这两种蛋白并不能杀灭所有K47型肺克。因此,本项目拟继续分离鉴定特异性靶向K47型肺克的解聚酶,建立解聚酶类抗菌蛋白库,为控制该型细菌感染提供抗生素以外的手段。在此基础上,利用解聚酶特异性将K47型肺克分成不同亚群,对不同亚群代表性菌株进行高通量测序与系统进化分析,建立解聚酶特异性亚群与分子进化亚群的对应关系,寻找决定解聚酶特异性的关键基因区域或关键基因,阐明解聚酶特异性作用K47型肺克的分子基础,为临床耐药肺克感染的个体化精准治疗提供新思路和新方法。
英文摘要
Klebsiella pneumoniae is an opportunistic pathogen causing community- and hospital-acquired infections. The emergence of drug-resistant K. pneumoniae has significantly increased the therapeutic challenges of managing the associated infections. Bacteriophage (phage) and its-derived depolymerases have recently been proposed as promising alternative or adjunctive treatment strategies to antibiotics against drug-resistant K. pneumoniae. Though phage and its-derived depolymerases are known to have excellent host specificity, knowledge of the governance mechanisms are rather limited. Previously, the applicant have identified two depolymerases from a K. pneumoniae phage, exhibiting potent antibacterial activity against capsular type K47 K. pneumoniae strains. However, our further studies indicated that these two depolymerases were not able to target all K47 K. pneumoniae strains. Therefore, the objective of the project is isolate and identify more phage-derived depolymerases targeting K47 K. pneumoniae and establish a comprehensive depolymerase library, facilitating the development of depolymerase as an effective treatment strategy other than antibiotics for K. pneumoniae infections. Furthermore, the project also aims to subtyping the K47 K. pneumoniae based on their depolymerase specificity. The represent strains of all K47 K. pneumoniae subtypes were conducted phylogenetic analysis using high throughput sequencing. The phylogenetic relationship of K47 K. pneumoniae subtypes combined with phage-derived depolymerases specificity were further analyzed. The acquire data will help in identifying the key gene or gene regions for determining the depolymerase specificity to reveal the molecular mechanisms governing the depolymerases specificity against K47 K. pneumoniae. Overall, the research outcomes from the proposed project will help in developing more efficient personalized treatments for drug-resistant K. pneumoniae infections.
肺炎克雷伯菌(简称“肺克”)是引起院内外感染的重要致病菌之一。近年来,碳青酶烯类耐药肺炎克雷伯菌感染的频繁出现,给临床治疗带来巨大挑战。目前,国内外多项研究证实噬菌体及其抗菌蛋白可有效对抗临床耐药细菌感染,具有开发为新型抗菌制剂的潜在应用前景。此前,项目负责人在一株可靶向K47型肺克噬菌体IME205中,鉴定出两种解聚酶类抗菌蛋白Dpo42与Dpo43,具有较好的抗菌效果。本项目再次收集了125株临床耐药肺克菌,使用wzi及wzc基因分型法鉴定出50株K47型肺克菌(40.00%, 50/125);单斑法测定出11株(22%,11/50)K47型肺克菌对IME205及其解聚酶不敏感。随后,从医院污水中分离出三株能够裂解上述11株耐药肺克菌的噬菌体(251、PH33、PH126),其中,PH33与PH126裂解谱相似,251与其他两株噬菌体的裂解谱完全不同,因此推测这些噬菌体联合IME205能够对抗超过4种K47型肺克亚群的体内外感染,对于耐药肺克感染的防控具有重要意义。与此同时,由于Dpo42与Dpo43可将K47型肺克菌分成不同亚群,因此本项目对56株肺克菌进行了高通量测序与分析,结果表明,对于Dpo43敏感组肺克,wzc序列在500aa以后出现一个相对突变热点区域,这可能与解聚酶Dpo42及Dpo43的敏感谱不同相关。此外,在鉴定肺克噬菌体的过程中,本项目还分离到两株可裂解皮特不动杆菌的噬菌体(IME-Ap7、IME-Ap1489),并克隆表达出相关噬菌体解聚酶。单斑法证实,两株噬菌体及其解聚酶分别对KL220型与KL207型皮特不动杆菌敏感;血清杀菌实验证实,两种解聚酶可有效增强血清杀菌能力,且不会破坏人红细胞,具有一定的安全性。总之,本研究为临床耐药菌感染的防控提供了新思路与新方法。
国内基金
海外基金